24th Conference on Retroviruses and Opportunistic Infections (CROI 2017), 13-16 February 2017, Seattle
26 June 2017. Related: Conference reports.
CROI 24 (Retrovirus) 2017
Impressive HIV pipeline at CROI 2017
26 June 2017. Related: Conference reports, Coinfections and complications.
24th Conference on Retroviruses and Opportunistic Infections (CROI 2017), 13-16 February 2017, Seattle
24 April 2017. Related: Conference reports.
Dose reduction potential of nanoparticle ARV formulations confirmed in humans
24 April 2017. Related: Conference reports, Antiretrovirals.
VRC01 in HIV-exposed newborns: first results support monthly injections for those at risk through breastfeeding
24 April 2017. Related: Conference reports, Antiretrovirals, Pregnancy, Paediatric care.
Raltegravir pharmacokinetic targets met in high-risk HIV-exposed infants
24 April 2017. Related: Conference reports, Antiretrovirals, Paediatric care, PK and drug interactions.
Tenofovir alafenamide exposure is modestly higher in children than adults
24 April 2017. Related: Conference reports, Antiretrovirals, Paediatric care.
New HIV diagnoses in children in UK and Ireland continue to decline
24 April 2017. Related: Conference reports, Paediatric care, PK and drug interactions, Diagnostics.
World Health Organisation paediatric dosing tool
24 April 2017. Related: Conference reports, Paediatric care, PK and drug interactions.
Pre-ART drug resistance in rural South Africa but limited clinical impact with good adherence
24 April 2017. Related: Conference reports, Antiretrovirals, Drug resistance.
Immune-based therapy canakinumab reduces inflammatory markers in HIV positive people on ART
24 April 2017. Related: Conference reports, Treatment strategies, Basic science and immunology.
Significant interaction between once-weekly isoniazid/rifapentine and daily dolutegravir: study stopped due to toxicity
24 April 2017. Related: Conference reports, PK and drug interactions.
Increased risk of IRIS with integrase inhibitors reported in two studies
24 April 2017. Related: Conference reports, Antiretrovirals, Treatment strategies, Coinfections and complications.
Breakthrough for treating XDR-TB and ameliorating TB-IRIS
24 April 2017. Related: Conference reports, Coinfections and complications, TB coinfection.
PrEP in pregnancy does not increase poor birth outcomes
24 April 2017. Related: Conference reports, Pregnancy, HIV prevention and transmission.
HIV cure research and basic science: capsules from CROI 2017
24 April 2017. Related: Conference reports, Cure-related research, Basic science and immunology.
24th Conference on Retroviruses and Opportunistic Infections (CROI 2017), 13-16 February 2017, Seattle
27 February 2017. Related: Conference reports.
Pharmacokinetics and full phase 2 results for bictegravir, a new integrase inhibitor
27 February 2017. Related: Conference reports, Antiretrovirals, PK and drug interactions.
New NNRTI doravirine is non-inferior to darunavir/r in phase 3 treatment naive study
27 February 2017. Related: Conference reports, Antiretrovirals.
NRTI GS-9131 resurfaces at CROI 2017: in vitro sensitivity to nuke-resistant HIV
27 February 2017. Related: Conference reports, Antiretrovirals.
Dolutegravir exposure increases when fixed dose combination tablets are crushed
27 February 2017. Related: Conference reports, Antiretrovirals, Paediatric care.
Pharmacokinetics, safety and efficacy of dolutegravir in very young children
27 February 2017. Related: Conference reports, Antiretrovirals, Paediatric care.
Efavirenz, tenofovir and emtricitabine associated with fewest adverse birth outcomes in Botswana
27 February 2017. Related: Conference reports, Antiretrovirals, Pregnancy.
Adverse pregnancy outcomes and risk factors in the PROMISE trial
27 February 2017. Related: Conference reports, Antiretrovirals, Pregnancy.
Women on lopinavir/ritonavir-based regimens at conception at higher risk of preterm delivery in UK study
27 February 2017. Related: Conference reports, Antiretrovirals, Pregnancy.
No increase in adverse birth outcomes with maternal TDF/FTC in US study
27 February 2017. Related: Conference reports, Pregnancy.
Dolutegravir monotherapy studies halted due to integrase resistance: dual therapy studies continue
27 February 2017. Related: Conference reports, Treatment strategies.
No evidence of accelerated brain ageing in HIV positive people on effective ART
27 February 2017. Related: Conference reports, Ageing and life expectancy.
Acute infection with wild-type HIV on PrEP with good drug levels
27 February 2017. Related: Conference reports, HIV prevention and transmission.
Fit for purpose: antiretroviral treatment optimisation Feb 2017
27 February 2017. Related: Conference reports, Fit for purpose, Antiretrovirals.
Seattle-lite: pre-conference workshops – watch online
27 February 2017. Related: Conference reports, On the web.